OverviewSuggest Edit

Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. The Company develops and commercializes products both within Fortress and through certain of its subsidiary companies, also known as Fortress Companies. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities. 

TypePublic
Founded2006
HQNew York, US
Websitefortressbiotech.com

Latest Updates

Employees (est.) (Dec 2018)88(+30%)
Job Openings1
Revenue (FY, 2018)$26.9 M(-85%)
Share Price (May 2019)$1.9

Fortress Biotech Office Locations

Fortress Biotech has an office in New York
New York, US (HQ)
2 Gansevoort St
Show all (1)

Fortress Biotech Financials and Metrics

Fortress Biotech Revenue

Fortress Biotech's revenue was reported to be $26.88 m in FY, 2018
USD

Revenue (Q1, 2019)

6.5m

Net income (Q1, 2019)

(16.3m)

EBIT (Q1, 2019)

(32.6m)

Market capitalization (22-May-2019)

126.5m

Closing stock price (22-May-2019)

1.9

Cash (31-Mar-2019)

116.4m
Fortress Biotech's current market capitalization is $126.5 m.
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

273.0k16.5m187.6m26.9m

Revenue growth, %

1810%

Sales and marketing expense

5.4m96.8m

General and administrative expense

10.1m21.6m28.2m40.5m53.4m
Quarterly
USDQ3, 2013Q1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Revenue

383.0k2.2m975.0k44.7m50.7m46.9m55.4m63.8m63.7m6.5m

Sales and marketing expense

24.5m24.0m24.9m25.6m31.4m28.4m

General and administrative expense

2.1m2.1m2.7m3.5m3.8m7.1m7.9m8.6m8.9m8.0m8.5m12.3m10.8m10.1m12.2m13.5m

R&D expense

5.4m4.5m1.6m1.6m2.4m9.1m7.7m6.3m7.3m8.4m11.7m15.9m12.0k17.5m16.1m23.3m
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2018

Cash

99.5m98.2m88.3m65.5m

Accounts Receivable

1.8m5.5m

Inventories

1.6m203.0k678.0k

Current Assets

100.0m99.8m109.6m111.2m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Cash

106.3m80.0m75.8m71.6m48.9m41.0m25.6m81.4m71.3m82.5m134.0m144.3m110.5m124.0m98.6m95.9m116.4m

Accounts Receivable

967.0k5.0m1.4m3.3m5.6m8.3m5.3m5.4m8.0m

Inventories

100.0k123.0k204.0k299.0k318.0k222.0k299.0k674.0k629.0k

Current Assets

106.5m80.5m76.5m72.1m69.6m62.0m66.6m84.3m76.6m98.6m151.8m190.2m184.1m200.2m171.5m159.5m136.5m
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2018

Net Income

(37.2m)(53.9m)(71.3m)(141.9m)

Depreciation and Amortization

17.0k944.0k1.4m

Inventories

(895.0k)(203.0k)(507.0k)

Accounts Payable

1.2m5.9m5.4m4.7m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Net Income

(27.4m)(7.4m)(16.7m)(12.5m)(19.0m)(19.9m)(16.6m)(33.0m)(50.0m)(14.6m)(37.5m)(73.8m)(38.2m)(73.9m)(102.5m)(16.3m)

Depreciation and Amortization

11.0k5.0k11.0k17.0k11.0k4.0k74.0k240.0k682.0k543.0k819.0k365.0k831.0k1.4m481.0k

Inventories

(100.0k)(123.0k)(1.0k)(96.0k)(115.0k)(51.0k)(128.0k)(503.0k)49.0k

Accounts Payable

252.0k(588.0k)(1.5m)(1.4m)664.0k920.0k1.3m169.0k3.6m5.4m(1.9m)(1.7m)4.2m8.3m1.2m(980.0k)3.7m
USDY, 2019

Financial Leverage

4 x
Show all financial metrics

Fortress Biotech Online and Social Media Presence

Embed Graph

Fortress Biotech News and Updates

Fortress Biotech Reports First Quarter 2019 Financial Results and Recent Corporate Highlights

NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and development-stage drugs and drug candidates, today announced financial results and …

Fortress Biotech Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Corporate Highlights

NEW YORK, March 18, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and development-stage drugs and drug candidates, today announced financial results an…

Fortress Biotech Announces CAEL-101 Strategic Partnership with Alexion Pharmaceuticals

Fortress-founded Caelum Biosciences to receive $60 million in a strategic equity investment and option fee

Fortress Biotech Recaps Corporate Highlights and Achievements in 2018

NEW YORK, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today recapped its corporate highlights and achievements in 2018.

Fortress Biotech Announces Agreement to Sell Its Majority Stake in National Holdings Corporation to NHC Holdings, LLC, a wholly-owned subsidiary of B. Riley Financial

NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced that it has entered into an agreement to sell its 56.1…

Fortress Biotech Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced financial results and recent corporate highlights for …
Show more

Fortress Biotech Frequently Asked Questions

  • When was Fortress Biotech founded?

    Fortress Biotech was founded in 2006.

  • How many employees does Fortress Biotech have?

    Fortress Biotech has 88 employees.

  • What is Fortress Biotech revenue?

    Latest Fortress Biotech annual revenue is $26.9 m.

  • What is Fortress Biotech revenue per employee?

    Latest Fortress Biotech revenue per employee is $305.5 k.

  • Who are Fortress Biotech competitors?

    Competitors of Fortress Biotech include Teewinot Life Sciences, BioCryst Pharmaceuticals and TiGenix.

  • Where is Fortress Biotech headquarters?

    Fortress Biotech headquarters is located at 2 Gansevoort St, New York.

  • Where are Fortress Biotech offices?

    Fortress Biotech has an office in New York.

  • How many offices does Fortress Biotech have?

    Fortress Biotech has 1 office.